Pernix Therapeutics Holdings, Inc.
|
(Name of Issuer) |
Common Stock, $0.01 par value
|
(Title of Class of Securities) |
71426V108
|
(CUSIP Number) |
Cooper C. Collins
33219 Forest West Drive
Magnolia, TX 77354
(832) 934-1825
|
(Name, address and telephone number of person
authorized to receive notices and communications)
|
March 4, 2014
|
(Date of event which requires filing of this statement) |
CUSIP No. 71426V108 | SCHEDULE 13D | Page 2 of 4 Pages |
1
|
NAME OF REPORTING PERSONS
Cooper C. Collins
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) þ
|
|||
3
|
SEC USE ONLY
|
|||
4
|
SOURCE OF FUNDS
N/A
|
|||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) o
N/A
|
|||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
|||
NUMBER OF
|
7
|
SOLE VOTING POWER
3,616,571 (1) (see Item 5)
|
|
|
SHARES
BENEFICIALLY
|
8
|
SHARED VOTING POWER
0
|
|
|
OWNED BY
EACH
|
9
|
SOLE DISPOSITIVE POWER
3,616,571(1) (see Items 5 & 6)
|
|
|
REPORTING
PERSON WITH
|
10
|
SHARED DISPOSITIVE POWER
0
|
|
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,616,571 (1) (see Item 5)
|
|||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES o
N/A
|
|||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.73%(2)
|
|||
14
|
TYPE OF REPORTING PERSON
IN
|
CUSIP No. 71426V108 | SCHEDULE 13D | Page 3 of 4 Pages |
Dated: March 10, 2014
|
/s/ Cooper C. Collins
|
||
Cooper C. Collins | |||